Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Discrepant antihypertensive dose recommendations.

Milos Milic1, Michael G Ziegler

  • 1UCSD Medical Center, San Diego, California 92103-8341, USA.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|March 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The risk of biopsy of phaeochromocytomas and paragangliomas.

The lancet. Diabetes & endocrinology·2026
Same author

The Groundswell Community Surf Therapy Intervention for At-Risk Women and Changes in Body Acceptance, Resilience, and Emotional Regulation.

Global advances in integrative medicine and health·2024
Same author

Sympathetic overactivity and nocturnal diuresis in obstructive sleep apnea alter the response to hypertension therapy.

Clinical hypertension·2024
Same author

Association of whole-person eigen-polygenic risk scores with Alzheimer's disease.

Human molecular genetics·2024
Same author

CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer's disease.

Translational psychiatry·2024
Same author

Opposing brain signatures of sleep in task-based and resting-state conditions.

Nature communications·2023
Same journal

Adiponectin improves the aortic dissection by inhibiting inflammatory cell infiltration and macrophage pyroptosis.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Electroacupuncture for essential hypertension: Mechanistic insights, current clinical evidence, and translational challenges.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Association of intracranial atherosclerotic stenosis with 1-year cognitive impairment after acute ischemic stroke or transient ischemic attack: a nationwide prospective cohort study.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Frailty as a mediator of the association between hyperuricemia and stroke risk: A prospective cohort study.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Synergistic impact of nondipper heart rate and blood pressure on left ventricular hypertrophy in essential hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

From clinic to home monitoring: Diagnostic strategies and evidence landscape of white-coat uncontrolled hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
See all related articles

Physicians often prescribe higher antihypertensive drug doses than recommended by JNC guidelines, potentially leading to adverse effects like hypokalemia and reduced efficacy, especially with clonidine.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Joint National Committee (JNC) guidelines provide evidence-based recommendations for hypertension management, including starting doses for antihypertensive medications.
  • Drug package inserts and the Physicians' Desk Reference (PDR) often list higher maximum effective doses compared to JNC recommendations.
  • Discrepancies exist between JNC guidelines and information sources commonly used by clinicians, such as PDAs and textbooks.

Observation:

  • A study found that JNC starting doses were recommended by PDAs only 35% of the time and textbooks 34% of the time.
  • Prescribing patterns at an academic medical center showed adherence to PDR guidelines for thiazide diuretics and calcium channel blockers, but closer alignment with JNC for beta-blockers.
  • Higher PDR-recommended thiazide doses were associated with hypokalemia.

Related Experiment Videos

  • High-dose clonidine, exceeding JNC recommendations and potentially counteracting its blood pressure-lowering effect, was prescribed in 14% of inpatient and 9% of outpatient cases.

    • Findings:

    • Physicians' prescribing patterns may not consistently align with JNC hypertension guidelines, particularly regarding starting doses.
    • Adherence to PDR recommendations over JNC guidelines can lead to the use of higher drug dosages.
    • The use of higher-than-recommended doses of certain antihypertensives, like clonidine, may be associated with adverse effects or diminished therapeutic benefit.

    Implications:

    • Conflicting information between package inserts/PDR and JNC guidelines influences clinical practice and physician prescribing habits.
    • Discrepancies can result in suboptimal hypertension treatment, potentially increasing risks of adverse events and treatment failure.
    • There is a need to harmonize recommendations and improve clinician awareness of evidence-based guidelines to optimize patient outcomes in hypertension management.